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The spectrum of respiratory syncytial virus-encoded proteins was examined in
infected cell extracts by standard polyacrylamide gel electrophoresis and by two-
dimensional gel analysis. Polyacrylamide gel electrophoresis analysis of a variety
of respiratory syncytial virus-infected, actinomycin D-treated cell lines revealed
the presence of as many as nine virus-encoded proteins. Seven of these nine
proteins were immunoprecipitated by anti-respiratory syncytial serum. Only one
major band of [3H]glucosamine was detected in infected cell extracts (Vp86),
whereas the reported major virion glycoprotein (Vp48-53) was difficult to detect in
infected cells when carbohydrate labels were employed. Two-dimensional gel
analysis easily identified seven viral proteins, and one other was tentatively
identified. The reported major virion glycoprotein again was not consistently
detected. The results of this study confirm the existence of a virus-coded
glycoprotein (Vp86) in infected cell extracts. The existence of this glycoprotein in
the purified virion has been in dispute, but the apparent low methionine content of
this protein may be the reason for this controversy.
Respiratory syncytial (RS) virus is the major
cause of lower respiratory tract illnesses during
infancy. Despite the recognition of this agent as
a major human pathogen, neither successful
preventive nor effective therapeutic strategies
have been developed to reduce the incidence of
this virus-induced disease. Recently, we identi-
fied several low-molecular-weight amidine-con-
taining compounds which interfere with the bio-
logical activity of RS virus in vitro and in vivo
(7, 8; unpublished data). The mechanism by
which these compounds exert their effect is
unknown. One possibility is that amidines inter-
fere with the synthesis or processing of RS virus
proteins. Of particular interest are the viral
proteins which are found on the surface of
infected cells, since the amidine inhibitors may
disrupt normal host cell-virus interactions. This
study was undertaken to define the spectrum of
RS virus-induced proteins in infected cells to
ascertain the impact of amidine inhibitors on
viral protein synthesis. The analysis was
achieved by standard polyacrylamide gel elec-
trophoresis (PAGE), two-dimensional PAGE,
and immunoprecipitation.
MATERIALS AND METHODS
Viruses and cells. The A2 and Long strains of RS
virus were obtained from R. M. Chanock (National
t Present address: Diagnostic Laboratory, New York State
College of Veterinary Medicine at Cormell University, Ithaca,
NY 14850.
Institute of Allergy and Infectious Diseases, Bethesda,
Md.). Viral stocks were prepared in HEp-2 cell cul-
tures propagated in minimal essential medium (MEM)
supplemented with 10% fetal bovine serum. All cell
lines (HEp-2, LLC-MK2, CV-1, and BS-C-1) were
obtained from Flow Laboratories, Inc., McLean, Va.
Viral stocks and cell lines were determined to be free
of mycoplasma contamination by the fluorochrome
technique of Chen (5). Extracts of cells grown in the
absence of antibiotics were incubated with mycoplas-
ma-free Vero cells for 5 days before fluorochrome
staining.
Isotopic labeling of virus-specific proteins. Cells used
for the labeling experiments were grown as monolay-
ers in 24-well trays (Falcon Plastics, Oxnard, Calif.).
RS virus (A2 strain) was added at an input multiplicity
of infection of 5 to 10. At 6 h postinfection, the
medium was removed and replaced with MEM plus
5% fetal bovine serum containing 2.5 ,ug of actinomy-
cin D per ml. Viral proteins were labeled at 20 to 24 h
postinfection with either 50 ,uCi of [35S]methionine in
250 ,ul of methionine-free MEM or 50 ,uCi of [3H]leu-
cine in 250 ,ul of leucine-free MEM. Viral glycopro-
teins were labeled with either 25 ,uCi of [3H]glucosa-
mine or 50 ,uCi of [3H]mannose in 250 ,ul of 1:1 MEM-
phosphate-buffered saline (PBS).
Cell extracts for one-dimensional PAGE were pre-
pared by solubilizing the cellular contents of a single
well in 400 ,ul of electrophoresis sample buffer (62.5
mM Tris-hydrochloride, pH 6.8; 2% sodium dodecyl
sulfate (SDS); 20% glycerol; 2% 2-mercaptoethanol).
Samples were heated at 95-C for 2 to 4 min and frozen
at -70°C. Extracts for nonequilibrium pH gradient
electrophoresis (NEPHGE) and isoelectric focusing
(IEF) were prepared as follows. Cell monolayers were
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rinsed two times with PBS and then scraped into 400
IlI of PBS. The cells were pelleted in a microcentrifuge
tube and then solubilized with 110 RI of 0.5% Nonidet
P-40 (NP-40) in water. The extracts were mixed in a
Vortex mixer and maintained at room temperature for
10 min. The nuclei were pelleted, and 100 p.l of
supernatant was added to 135 mg of urea. This was
followed by the addition of 7 R1 of 20%o SDS, 13 ILI of
ampholines (pH 3.5 to 10), 13 ,u of 2-mercaptoethanol,
and 20 IL1 of NP-40. Extracts were frozen at -70°C.
Immunoprecipitation. Cell extracts for immunopre-
cipitation were solubilized in 0.5% NP-40 in PBS.
Antibody to RS virus was purchased from Flow Labo-
ratories. Since this antiserum was prepared with RS
virus grown in HEp-2 cells, all extracts for immuno-
precipitation were prepared using CV-1 cells or LLC-
MK2 cells. Immunoprecipitates were prepared by the
procedure of Hayes et al. (9), with Formalin-fixed
Staphylococcus aureus (Cowan 1 strain).
One-dimensional PAGE. Slab gels (100 by 140 by 1.5
mm) consisted of 10%o acrylamide (0.27% bisacryla-
mide), 12.5% acrylamide (0.14% bisacrylamide), or
15% acrylamide (0.086% bisacrylamide). The discon-
tinuous buffer system of Laemmli and Favre (10) was
used with a 3.5% acrylamide stacking gel. Molecular
weight estimations of RS virus proteins were made
with either the proteins of vesicular stomatitis virus
(G, 69,000; N, 50,000; and M, 29,000) (19) or marker
proteins from Sigma Chemical Co., St. Louis, Mo.
(bovine albumin, 66,000; egg white albumin, 45,000;
trypsinogen, 24,000; lactoglobin, 18,400; and lyso-
zyme, 14,300) as markers. Linear regression analysis
was used to estimate molecular weights.
Two-dimensional PAGE. First-dimension IEF gels
(ampholines, pH 5 to 7) were prepared according to
O'Farrell (14), and NEPHGE (ampholines, pH 3.5 to
10) was performed as described by O'Farrell et al.
(15). Electrode solutions were 0.02 M NaOH and 0.01
M phosphoric acid. For IEF, electrophoresis was for
18 h at 350 V followed by 1 h at 700 V; for NEPHGE,
gels were run at 500 V for 5 h. First-dimension
cylindrical gels (2.5 mm) were extruded into tubes
containing sample buffer and were frozen at -70°C.
Two-dimensional PAGE was performed as de-
scribed by Dubovi and Wagner (8). First-dimension
gels were equilibrated for 1 h at 37°C in sample buffer
and then immobilized on top of slab gels with 1%
agarose. Slab gels were analyzed by autoradiography
for 35S and fluorography for 35S or 3H (2) with Kodak
X-OMAT XRP-5 film.
Chemicals and isotopes. Reagents for PAGE were
purchased from Bio-Rad Laboratories, Richmond,
Calif. Isotopes L-[355]methionine (890 to 1,110 Cil
mmol), D-[6-3Hlglucosamine hydrochloride (30 Ci/
mmol), and D-[2-3H]mannose (16 Ci/mmol) were ob-
tained from Amersham Corp., Arlington Heights, Ill.,
and L-[4,5-3H]leucine (56.8 Ci/mmol) was purchased
from ICN Pharmaceuticals, Irvine, Calif. Ampholines
were obtained from LKB Instruments Inc., Rockville,
Md., and actinomycin D was from Sigma.
RESULTS
Labeling of RS virus-infected cells with
[lSJmethionine. The initial set of experiments
was designed to explore conditions which would
provide acceptable labeling of RS virus proteins
in infected cells. Since RS virus infection does
not lead to a rapid shutoff of host cell protein
synthesis (12), actinomycin D was added to
infected cells at various times, and viral proteins
were labeled with [35S]methionine 18 to 24 h
postinfection. One-dimensional PAGE of RS
virus-infected CV-1 cell extracts showed the
presence of at least eight new polypeptides
(Vp68, Vp5O, Vp45, Vp36, Vp33, Vp24, Vpl8,
and Vpl5 [Fig. 1 and 2]). These same polypep-
tides were labeled with [35S]methionine in RS
virus-infected Vero, BS-C-1, LLC-MK2, A549,
HEp-2, and BHK-21 cell lines.
Labeling of RS Virus-infected cells with [3H]glu-
cosamine. RS virus-infected CV-1 and LLC-
MK2 cells were labeled with [3H]glucosamine
for 3 h, beginning 24 h postinfection. In both cell
lines, one major band of protein was labeled
with [3H]glucosamine (Fig. 1). This band did not
coincide with any [35S]methionine-labeled poly-
peptide. PAGE analysis of a mixture of [3H]glu-
cosamine- and [35S]methionine-labeled cell ex-
tracts confirmed the uniqueness of the protein
designated Vp86 (data not shown). Longer label-
ing times with [3H]glucosamine or [3H]mannose
did not alter the pattern from that shown in Fig.
1. Longer development times of the fluorograms
revealed minor bands of carbohydrate label in
the areas of Vp5O and Vp24. Trichloroacetic
acid precipitates of supernatant fluids from in-










FIG. 1. SDS-PAGE of [3H]glucosamine-labeled RS
virus-infected CV-1 (lanes A and B) and LLC-MK2
(lanes C and D) cells. Actinomycin D-treated, control
(lanes A and C), and RS virus infected cells (lanes B
and D), were labeled with [3H]glucosamine for 3 h,
beginning 24 h postinfection. Gels were processed for
fluorography (2). Lanes E and F are CV-1 control and
infected cell extracts labeled with [35S]methionine,
respectively. The spaces between lanes D and E were
blank wells. Gel concentration, 12.5%.
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FIG. 2. SDS-PAGE of RS virus-infected LLC-
MK2 cells. Actinomycin D-treated cells, LLC-MK2
control (lanes A and C) and RS virus-infected (lanes B
and D), were labeled with [3H]leucine for 1 h (lanes A
and B) or 3 h (lanes C and D), beginning 24 h
postinfection. Gel concentration, 12.5%.
postinfection) with [3H]glucosamine also
showed only one major band of carbohydrate
label (data not shown). In this instance, the
molecular weight was reduced slightly as com-
pared with the cell-associated glycoprotein
Vp86. This may reflect the proteolytic release of
the glycoprotein as was seen with the G protein
of vesicular stomatitis virus (13). It also should
be noted that the glycoprotein labeled in CV-1
cells migrated faster than the glycoprotein la-
beled in LLC-MK2 cells (Fig. 1). This may
reflect different extents of glycosylation in the
two cell lines.
[3H]leucine labeling of infected cells. The data
in Fig. 1 clearly demonstrate the existence of a
virus-induced glycoprotein in RS virus-infected
cell extracts which did not correspond to a
[35S]methionine-labeled protein. In an attempt
to resolve this discrepancy, RS virus-infected
cells were labeled with [3H]leucine. The exis-
tence of Vp86 is clearly shown with the 3-h
labeling period, and a faint band is even evident
with a 1-h labeling period (Fig. 2). Labeling
times as long as 20 h with [35S]methionine failed
to demonstrate this polypeptide. Since [35S]me-
thionine has been used for many of the studies of
RS virus proteins, this could explain the inability
of these workers to detect a Vp86 glycoprotein
in RS virus-infected cells (3, 4, 17, 20).
Immunoprecipitation of labeled proteins. The
detection of new protein bands in virus-infected
cells strongly suggests a viral origin for these
proteins. Additional support for this supposition
is achieved by demonstrating that these proteins
are immunologically related to virion proteins.
To this end, RS virus-infected LLC-MK2 cell
extracts were reacted with a horse anti-RS virus
serum raised against virus grown in HEp-2 cells.
Analysis of the immunoprecipitates indicated
that at least Vp86, Vp68, Vp5O, Vp45, Vp36,
Vp33, and Vp24 are of viral origin (Fig. 3). The
low activity toward Vp18 and Vp15 is not sur-
prising since these proteins have not been de-
tected in the virion (4, 11, 16, 17). Sera from
cotton rats productively infected with RS virus
also showed a similar pattern of immunoprecipi-
tation. Finally, [3H]glucosamine-labeled Vp86
also specifically reacted with anti-RS serum
(data not shown).
Two-dimensional gel analysis of RS virus-in-
fected cells. By standard PAGE, nine RS virus-
induced proteins were identified in a variety of
infected cell extracts (Fig. 1 and 2). Confirma-






FIG. 3. Immunoprecipitation of [3H]leucine-la-
beled proteins from RS virus-infected LLC-MK2 cells.
RS virus-infected LLC-MK2 cells were labeled for 3 h,
beginning 24 h postinfection, with [3H]leucine. Cells
were solubilized with 0.5% NP-40 in PBS. Extracts
that were preabsorbed with Formalin-fixed S. aureus
(Cowan 1 strain) were incubated with horse anti-RS
serum (Flow Laboratories) for 1 h at room tempera-
ture. Antigen-antibody complexes were collected us-
ing the staphylococcal A protein binding technique (9).
Pelleted complexes were washed three times and then
dissolved in electrophoresis sample buffer. Gel con-
centration, 12.5%.
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NEPHGE (15) and IEF (14) gels in a two-
dimensional analysis of RS virus-infected cell
extracts. Positive identification of seven viral
proteins was made by NEPHGE gel analysis
(Fig. 4). Proteins Vp86, Vp45, Vp36, Vp33,
Vp24, Vpl8, and Vpl5 were easily identified
with the [3H]leucine label, whereas Vp86 was
absent with a [35S]methionine label. Protein
Vp68 was difficult to identify in all samples, but
a tentative location is indicated in Fig. 4. Protein
Vp50 also was not positively identified, but a
band is occasionally seen as in Fig. 4 in the
basic region of the gel above the Vp45 streak. A
protein of this molecular weight (VGP48) was
identified as a virion glycoprotein (4, 11, 16, 17),
but its existence in infected cells is difficult to
confirm (4). The same viral proteins shown in
Fig. 4 were identified with RS virus-infected
HEp-2 cell extracts labeled in the absence of
actinomycin D (data not shown).
The NEPHGE gel analysis also provides in-
formation on the acidic or basic nature of the
viral proteins. Clearly, Vp86 and Vp36 are acid-
ic, whereas Vp33, Vp24, and Vpl8 are basic.
Protein Vp45 was not resolved into a single band
by this technique. This may be because this
protein, which in all probability is the nucleo-
capsid protein (20), may be tightly associated
with the RNA and the solubilization procedure
for NEPHGE gels did not fully disrupt this
interaction. Protein Vp36, which can run as a
diffuse band on standard gels, also presents a
unique profile on two-dimensional gels. The
large trailing spot in Fig. 4 was characteristic of
Vp36 on the second-dimension slab gel.
Since the existence of Vp86-like polypeptides
has been in question, infected cell extracts were
subjected to IEF to clearly separate Vp86 from
other acidic proteins which might remain at the
origin ofNEPHGE gels. These gels show that no
host cell proteins migrate to a position similar to
that of Vp86 (Fig. 5). Viral protein Vp36 also is
resolved at the acidic end of the gel, whereas
Vpl5 is somewhat less acidic. The basic proteins
(Vp68, Vp33, Vp24, and Vp18) did not migrate
from the origin, which was excluded from this
photograph.
DISCUSSION
This study was initiated in response to the
recent findings that amidine-containing com-
pounds specifically interfere with RS virus-host
cell interactions (6, 7). To ascertain the mecha-
nism by which these compounds inhibit RS
virus, it is necessary to identify the RS virus-
specific proteins found in and on infected cells.
The data presented in this report argue strongly
for the existence in infected cells of at least nine
RS virus-specific polypeptides (Vp86, Vp68,
Vp5O, Vp45, Vp36, Vp33, Vp27, Vpl8, and
Vpl5). This spectrum of viral proteins was de-
tected in at least six different cell lines. A 10th
protein with a molecular weight similar to that of
the L protein of vesicular stomatitis virus
(Vp190) was inconsistently detected in RS virus-
infected cells (data not shown). This protein
probably corresponds to the Vp200 protein de-
tected by others (4, 17).
Of the nine proteins identified in this work,
seven were immunoprecipitable with RS virus-
specific antiserum (Vp86, Vp68, Vp5O, Vp45,
Vp36, Vp33, and Vp27 [Fig. 3]). At present,
there is still some doubt expressed as to the viral
nature of a glycoprotein with a molecular weight
similar to that of Vp86 (17). Bernstein and
Hruska (1) also found an immunoprecipitable
glycoprotein similar to Vp86 in RS virus-infect-
ed cells; however, Pringle et al. (17) could not
confirm its viral origin, even though a specific
association of this polypeptide with a productive
RS virus infection was established. Glycopro-
tein Vp86 was the major protein detected in RS
virus-infected cell extracts of LLC-MK2 and
CV-1 cells when a [3H]glucosamine label was
employed (Fig. 1). In addition, supernatant flu-
ids from these cells contained a single glycopro-
tein with a slightly lower molecular weight than
that of Vp86. Both [3H]leucine-labeled Vp86 and
[3H]glucosamine-labeled Vp86 were immuno-
precipitable. Two-dimensional gel analysis of
control and RS virus-infected cell extracts (Fig.
4 and 5) confirmed that Vp86 existed only in
infected cells. These data taken together argue
strongly for the viral origin of Vp86.
Part of the problem in identifying Vp86 as a
viral protein may lie in the difficulty in labeling
this protein with [35S]methionine. Although
[3H]glucosamine easily labeled this polypeptide,
[35S]methionine incorporation into Vp86 is very
limited (Fig. 1) (1, 17). However, Vp86 is easily
labeled with [3Hlleucine (Fig. 2) or a mixture of
3H-amino acids (11). This labeling pattern sug-
gests that Vp86 is not a precursor to the reported
major virion glycoprotein VGP48 since this pro-
tein is labeled with [35S]methionine.
The data in Fig. 3 also confirm the viral origin
of Vp68. Bernstein and Hruska (1) detected a
similar polypeptide (Vp73) but were not able to
show immunoprecipitation with RS virus-spe-
cific rabbit antiserum. Ueba (18) also found a
comparable protein (Vp75) in purified virus, but
others have not reported the existence of this
polypeptide (3, 4, 11, 16, 17, 20). The data in Fig.
2 demonstrate a consistent finding regarding
Vp68; i.e., more label is found in Vp68 in a 1-h
labeling period than in a 3-h labeling period. In
addition, pulse-chase experiments show a de-
crease in Vp68 during the chase period (data not






















FIG. 4. Separation of control (A) and RS virus-infected (B) LLC-MK2 cell proteins in two-dimensional gels
by NEPHGE. RS virus-infected LLC-MK2 cells were labeled for 3 h with [3H]leucine, beginning 24 h
postinfection. Cells were solubilized with 0.5% NP-40 and processed as described in the text. Samples were
electrophoresed on 13.5-cm-long gels at 500 V for 5 h. After equilibration in sample buffer, the gels were
immobilized with 1% agarose on top of a 0.75-mm-thick 12.5% polyacrylamide gel. A sample of infected cell




RESPIRATORY SYNCYTIAL VIRUS PROTEINS

















FIG. 5. IEF of control (A) and RS virus-infected (B) cell extracts. Cells were labeled and solubilized as
described in the legend to Fig. 4. First-dimension gels were run for 18 h at 350 V, followed by 1 h at 700 V. The
pH of the first-dimension gel was measured by suspending 1-cm segments of a parallel gel in 1 ml of water.
precursor to another RS virus protein(s). Cash et
al. (3) detected a polypeptide of 61,000 daltons
(VI61) in in vitro translation experiments with
mRNA from RS virus-infected cells. Recent
speculation on the nature of V161 suggested that
it might be the unglycosylated precursor for the
glycoprotein GP1 (Vp86) (17). The data in Fig. 1
make this highly unlikely if V161 and Vp68 are
identical polypeptides, since Vp68 is labeled
with [35S]methionine whereas Vp86 is not.
Two viral proteins of less than 20,000 daltons
were demonstrated in this study. Two-dimen-
sional PAGE analysis showed that these pro-
teins are unique as Vpl8 is basic, whereas Vpl5
is acidic. These are believed to be primary gene
products in that the inclusion of protease inhibi-
tors did not alter the polypeptide profile found in
Fig. 1 (data not shown). No previous report has
identified both of these proteins. Cash et al. (4)
reported the existence of a 10,500-dalton protein
in RS virus-infected cells, and Bernstein and
Hruska (1) detected a 17,000-dalton protein
which appeared to label with [3H]glucosamine.
Attempts to label Vpl8 with [3H]glucosamine
were not successful, but a diffuse band of
[3H]glucosamine label appeared to be associated
with Vp24 (data not shown).
At present, there are eight identified comple-
mentation groups of RS virus (17). This study
has presented evidence for at least nine viral
proteins in RS virus-infected cells by using a
combination of one-dimensional and two-dimen-
sional PAGE. The function of each of these
polypeptides has not been established. In partic-
ular, the role of Vp86 in the replication cycle
needs to be established. Work is now in progress
to determine whether the amidine inhibitors
interact with Vp86.
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